Evidence map›Paper›PMID 39223297›Full record

ArticleLeukemia2024

Correction: Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials.

Elias Jabbour, Jane Apperley, Jorge Cortes, Delphine Rea, Michael Deininger, Elisabetta Abruzzese, Charles Chuah, Daniel J DeAngelo, Andreas Hochhaus, Jeffrey H Lipton and 10 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Elias JabbourThe University of Texas MD Anderson Cancer Center, Houston, TX, USA. ejabbour@mdanderson.org.ORCID http://orcid.org/0000-0003-4465-6119
Jane ApperleyImperial College London, London, UK.ORCID http://orcid.org/0000-0002-1710-1794
Jorge CortesGeorgia Cancer Center, Augusta, GA, USA.ORCID http://orcid.org/0000-0002-8636-1071
Delphine ReaHôpital Saint-Louis, Paris, France.ORCID http://orcid.org/0000-0001-5379-7461
Michael DeiningerVersiti Blood Research Institute, Medical College of Wisconsin, Milwaukee, WI, USA.ORCID http://orcid.org/0000-0002-2987-1331
Elisabetta AbruzzeseS. Eugenio Hospital, Tor Vergata University, Rome, Italy.ORCID http://orcid.org/0000-0001-5228-6491
Charles ChuahSingapore General Hospital, National Cancer Centre Singapore, Duke-NUS Medical School, Singapore, Singapore.
Daniel J DeAngeloDana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0001-7865-2306
Andreas HochhausUniversitätsklinikum Jena, Jena, Germany.ORCID http://orcid.org/0000-0003-0626-0834
Jeffrey H LiptonPrincess Margaret Cancer Centre, Toronto, ON, Canada.
Michael MauroMemorial Sloan Kettering, New York, NY, USA.ORCID http://orcid.org/0000-0002-2251-4032
Franck NicoliniCentre Léon Bérard, Lyon, France.
Javier Pinilla-IbarzH. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Gianantonio RostiIRST/IRCCS "Dino Amadori", Meldola (FC), Italy.
Philippe RousselotHospital Mignot University de Versailles Saint-Quentin-en-Yvelines, Paris, France.
Neil P ShahUniversity of California San Francisco, San Francisco, CA, USA.
Moshe TalpazComprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA.
Alexander VorogTakeda Development Center Americas, Inc., Lexington, MA, USA.
Xiaowei RenTakeda Development Center Americas, Inc., Lexington, MA, USA.
Hagop KantarjianThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-1908-3307

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39223297
PMCPMC11436350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.